Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Scleroderma and Related Disorders|April 6, 2022
Mycophenolic acid drug monitoring in patients with systemic sclerosis associated with diffuse skin and/or pulmonary involvement: A monocentric and retrospective French studyPaul Legendre, Benoit Blanchet, Raphael Porcher, et al.
Clinical Immunology (Orlando, Fla.)|February 8, 2022
Erythroblastic synartesis associated with lymphoproliferative disorder: There can be more than meets the eyeCamille Mettler, Cassandre Petit, Vincent Ernest, et al.
British Journal of Haematology|June 19, 2026
Glomeruloid haemangioma in Erdheim-Chester disease: An atypical skin manifestation associated with elevated vascular endothelial growth factor-A levelsJerome Razanamahery, Matthias Papo, Francesco Pegoraro, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Autoantibodies versus Skin Fibrosis Extent in Systemic Sclerosis: A Case-Control Study of Inverted PhenotypesAshley Tieu, Benjamin Chaigne, Bertrand Dunogué, et al.
Ocular Immunology and Inflammation|April 12, 2022
Hypervirulent Klebsiella Pneumoniae, an Emerging Cause of Endogenous Endophthalmitis in A French Center: A Comparative Cohort StudyJean-Philippe Martellosio, Nabil Gastli, Rebecca Farhat, et al.
Kidney International Reports|April 14, 2025
Pilot Study of Diagnostic Performances of Vascular Biomarkers Soluble fms-Like Tyrosine Kinase and Placental Growth Factor in Scleroderma Renal CrisisAïcha Kante, Paul Legendre, Bérangère S Joly, et al.
International Journal of Surgical Pathology|May 9, 2023
EBV-Positive Inflammatory Follicular Dendritic Cell Sarcoma of the Spleen: Report of an Aggressive Form With Molecular CharacterizationAlistair Baber, Paul Legendre, Patricia Palmic, et al.
Rheumatology (Oxford, England)|October 26, 2021
Rituximab plus methotrexate combination as a salvage therapy in persistently active granulomatosis with polyangiitisBoris Sorin, Maxime Samson, Cécile-Audrey Durel, et al.
Rheumatology (Oxford, England)|September 5, 2022
Anti-PM-Scl antibodies-positive patients encompass three different groups with distinct prognosesPaul Breillat, Kuberaka Mariampillai, Paul Legendre, et al.
Therapeutic Drug Monitoring|November 24, 2020
Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 PatientsLaurent Chouchana, Sana Boujaafar, Ines Gana, et al.
Pageof 3